Detection of relevant variants of the KRAS and the BRAF gene
Scientists of the Saarland University and the Charité Berlin established an assay which allows the selective detection of all 14 clinically relevant variants of the KRAS gene (codon 12 and 13) and the BRAF gene (codon 600-2). Compared to the most frequently used technique of direct sequencing, the assay shows a much higher sensitivity with a reliable detection limit of 5%, compared to 20% of mutated DNA in a wild type background, with causing only one third of the costs of direct sequencing, as the assay does not require complicated establishment procedures, expensive lab automation or technical replicates.
Further Information: PDF
Universität des Saarlandes Wissens- und Technologietransfer GmbH PatentVerwertungsAgentur der saarländischen Hochschulen
Phone: +49 (0)681/302-71302
Contact
Dipl.-Kfm. Axel Koch (MBA), Dr. Conny Clausen, Dr. Hauke Studier, Dr. Susanne Heiligenstein
Media Contact
All latest news from the category: Technology Offerings
Newest articles
An Endless Loop: How Some Bacteria Evolve Along With the Seasons
The longest natural metagenome time series ever collected, with microbes, reveals a startling evolutionary pattern on repeat. A Microbial “Groundhog Year” in Lake Mendota Like Bill Murray in the movie…
Witness Groundbreaking Research on Achilles Tendon Recovery
Achilles tendon injuries are common but challenging to monitor during recovery due to the limitations of current imaging techniques. Researchers, led by Associate Professor Zeng Nan from the International Graduate…
Why Prevention Is Better Than Cure—A Novel Approach to Infectious Disease Outbreaks
Researchers have come up with a new way to identify more infectious variants of viruses or bacteria that start spreading in humans – including those causing flu, COVID, whooping cough…